Based on the ProShares UltraShort Nasdaq Biotechnology stock forecast from 0 analysts, the average analyst target price for ProShares UltraShort Nasdaq Biotechnology is not available over the next 12 months. ProShares UltraShort Nasdaq Biotechnology’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ProShares UltraShort Nasdaq Biotechnology is Bullish , which is based on 13 positive signals and 3 negative signals. At the last closing, ProShares UltraShort Nasdaq Biotechnology’s stock price was USD 22.71. ProShares UltraShort Nasdaq Biotechnology’s stock price has changed by -5.06% over the past week, -2.24% over the past month and +26.24% over the last year.
No recent analyst target price found for ProShares UltraShort Nasdaq Biotechnology
No recent average analyst rating found for ProShares UltraShort Nasdaq Biotechnology
Company Overview ProShares UltraShort Nasdaq Biotechnology
Bisalloy Steel Group Limited engages in the manufacture and sale of quenched and tempered, high-tensile, and abrasion resistant steel plates in Australia, Indonesia, Thailand, and internationally. It offers wear, structural, and armor grade specialty steels. The company also provides protection steel products. It serves mining, construction, mineral processing, agriculture, general fabrication, pressure vessel, and defense industries. The company markets its products through distributors and agents, as well as directly to original equipment manufacturers. It provides its products under the BISALLOY and BISPLATE brand names. Bisalloy Steel Group Limited was founded in 1980 and is headquartered in Unanderra, Australia. Address: Brandes Investment Partners, L.P. Read Less
Bisalloy Steel Group Limited engages in the manufacture and sale of quenched and tempered, high-tensile, and abrasion resistant steel plates in Australia, Indonesia, Thailand, and internationally. It offers wear, structural, and armor grade specialty steels. The company also prov...Read More
Frequently Asked Questions About ProShares UltraShort Nasdaq Biotechnology (BIS) Stock
Stock Target Advisor's fundamental analysis for ProShares UltraShort Nasdaq Biotechnology's stock is Bullish .
BIS stock's dividend yield is 6.22%.
Our analysis grades BIS stock's dividend yield at A+. This means that BIS stock's dividend yield is above 100% of the stocks in the Trading--Inverse Equity sector in the NSD exchange.
Based on this BIS may be a good dividend stock for its sector.
Unfortunately we do not have enough data on BIS's stock to indicate what its average analyst target is.
BIS stock's Price/Earning ratio is 8.04.
Our analysis grades BIS stock's Price / Earning ratio at A+. This means that BIS stock's Price/Earning ratio is above 0% of the stocks in the Trading--Inverse Equity sector in the NSD exchange.
Based on this BIS may be undervalued for its sector.
The last closing price of BIS's stock was USD 22.71.
The most recent market capitalization for BIS is USD 0.10B.
Unfortunately we do not have enough analyst data on BIS's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ProShares UltraShort Nasdaq Biotechnology's stock.
As per our most recent records ProShares UltraShort Nasdaq Biotechnology has 0 Employees.
Sorry we do not have any infomation available on ProShares UltraShort Nasdaq Biotechnology's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
